Tetsuwan Scientific is a technology company.
Tetsuwan Scientific has raised $3.0M across 1 funding round.
Tetsuwan Scientific has raised $3.0M in total across 1 funding round.
# High-Level Overview
Tetsuwan Scientific is an AI-driven robotics company that develops autonomous AI scientists—fully autonomous systems combining advanced artificial intelligence with laboratory robots to conduct scientific experiments independently[1]. Founded in 2023, the company addresses a fundamental bottleneck in scientific research: the limited speed, throughput, and scalability of human scientific labor[2]. Rather than automating individual tasks, Tetsuwan focuses on building intelligent agents capable of reasoning, reacting to experimental data, and making autonomous decisions to advance discovery[2].
The company's core offering targets life sciences research, where it helps measure effectiveness, determine dosage, and accelerate the pace of experimentation. By automating routine lab work—such as pipetting and liquid handling—Tetsuwan aims to free human scientists to focus on creative and intellectual synthesis while simultaneously scaling scientific productivity[1][2].
# Origin Story
Tetsuwan Scientific was founded in 2023 by Cristian Ponce (CEO) and Théo Schäfer (CTO), who met through Entrepreneur First's U.S. program[1]. Ponce holds a background in biological engineering from Caltech and contributed to research in full-genome engineering[1]. Schäfer completed his master's degree in Mechanical Engineering from ETH Zurich, with thesis work conducted at MIT[1]. The duo bonded over shared frustrations about the manual drudgery of lab work—particularly the tedious hours spent pipetting liquids between tubes in genetic engineering[3].
The company's breakthrough came in May 2024 when the co-founders witnessed OpenAI's multimodal product launch. They recognized a critical insight: large language models had already developed strong scientific reasoning capabilities but lacked physical agency to execute their own suggestions[3]. This "light bulb moment" crystallized their vision—combining LLM reasoning with robotic manipulation to create truly autonomous scientific agents[3].
The team rapidly expanded to seven members, drawing expertise from prestigious institutions including Caltech, ETH Zurich, MIT, and UC Davis[1]. The company is advised by Aaron Kimball, former CTO of Zymergen and Director of Engineering at Benchling[1].
# Core Differentiators
# Role in the Broader Tech Landscape
Tetsuwan is riding the convergence of three powerful trends: the maturation of large language models with scientific reasoning capabilities, advances in robotic manipulation, and the growing recognition that scientific discovery itself is a labor bottleneck constraining innovation[1][3].
The timing is particularly significant. Academic breakthroughs in 2023—including CMU's Coscientist and EPFL's ChemCrow—demonstrated that AI-driven language models could partner with robots to conduct experiments[1]. Tetsuwan is among the first companies to commercialize this research, positioning itself at the intersection of generative AI and life sciences automation[1].
The company's vision aligns with a broader shift in how industries approach automation: moving from task-level efficiency gains to system-level intelligence. In this context, Tetsuwan represents a new category—not just lab automation, but autonomous scientific agents that can reason about experimental design and adapt to results in real time[2].
# Quick Take & Future Outlook
Tetsuwan has demonstrated early traction with its first alpha customer, La Jolla Labs, a biotech company developing RNA therapeutic drugs[3]. The company raised $2.7 million in an oversubscribed pre-seed round led by 2048 Ventures, with participation from Carbon Silicon Ventures, Everywhere Ventures, and influential biotech angels[3].
Looking ahead, the company's success will depend on three factors: (1) expanding beyond its initial alpha customer to demonstrate repeatability across different research domains, (2) improving the robustness of autonomous decision-making in unpredictable lab environments, and (3) navigating the regulatory and safety considerations of deploying autonomous systems in research settings.
If Tetsuwan executes effectively, it could fundamentally reshape how scientific research is conducted—transforming labs from human-centric workspaces into hybrid environments where AI scientists handle routine experimentation while human researchers focus on hypothesis generation and creative synthesis. This shift would represent one of the most consequential applications of AI to date, directly accelerating the pace of scientific discovery itself[1].
Tetsuwan Scientific has raised $3.0M in total across 1 funding round.
Tetsuwan Scientific's investors include 2048 Ventures, Jenny Fielding, Scott Hartley, Everywhere Ventures (The Fund), Impellent Ventures, Trucks Venture Capital, Volition Capital, Jason Robins.
Tetsuwan Scientific has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2024 | $3.0M Seed | 2048 Ventures, Jenny Fielding, Scott Hartley, Everywhere Ventures (The Fund), Impellent Ventures, Trucks Venture Capital, Volition Capital, Jason Robins |